Archive: David Brennan
The pharmaceutical industry is committed to helping Congress pass comprehensive health care reform that extends affordable, quality health and prescription drug coverage to all Americans while also protecting medical innovation. However, implementing changes to the system can take time, and...
By David Brennan | November 6, 2009; 09:53 AM ET | Comments (2)
Sen. Max Baucus and the Finance Committee have delivered a health reform proposal that can improve the health-care system by expanding health and prescription drug coverage, increasing quality and making care more affordable.
By David Brennan | October 15, 2009; 02:52 PM ET | Comments (0)
Like the President, we at AstraZeneca believe all sides in the debate must come together to advance solutions that build on the strengths of the U.S. health-care system and address its weaknesses. Because our most important contribution to the health system is the medicines we make, we will continue to advocate for the protection of America's lead in the search for new medical cures and treatments.
By David Brennan | September 11, 2009; 12:24 PM ET | Comments (0)
A focus on disease prevention and management, improved technologies and innovative medicines will improve health outcomes and lessen existing health system strains on our economy.
By David Brennan | July 21, 2009; 04:01 PM ET | Comments (2)
We foster an environment that encourages the discovery of lifesaving medicines and treatments.
By David Brennan | June 30, 2009; 09:50 AM ET | Comments (1)
Our industry's $80 billion agreement with the White House and Sen. Max Baucus (D-Mont.) demonstrates that pharmaceutical companies are willing to step up to the plate and do their share to help enact health-care reform this year.
By David Brennan | June 22, 2009; 08:28 PM ET | Comments (1)
As the debate progresses, we believe the President, Congress and everyone engaged in the debate must recognize the need for the health-care system to promote and protect America's status as the leader in medical innovation as we seek to cure and treat the world's most debilitating - and costly - diseases.
By David Brennan | June 15, 2009; 04:23 PM ET | Comments (0)